Completed PHASE4 INTERVENTIONAL 2-arm
NCT07406555
Comparison of C-Reactive Protein Levels in Traumatic Brain Injury Patients Undergoing Craniotomy With and Without Dexmedetomidine (DEX-CRP)
Differences in C-Reactive Protein Levels Between Traumatic Brain Injury Patients Receiving Dexmedetomidine and Those Not Receiving Dexmedetomidine Undergoing Craniotomy at Prof. Dr. Margono Soekarjo Regional General Hospital, Purwokerto
Sponsor: Universitas Jenderal Soedirman
Conditions
Traumatic Brain Injury
Interventions
Dexmedetomidine Sufentanyl
Updated 1 time since 2026 Last updated: Feb 12, 2026 Started: Oct 27, 2025 Primary completion: Oct 28, 2025 Completion: Nov 24, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07406555, this PHASE4 trial focuses on Traumatic Brain Injury and remains completed. Sponsored by Universitas Jenderal Soedirman, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Universitas Jenderal Soedirman
Data source: Universitas Jenderal Soedirman
For direct contact, visit the study record on ClinicalTrials.gov .